Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in OLMA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 10.4M | $154.9M | +106.8% | 11.891% | 0.01% |
| 2 | Paradigm Biocapital Advisors LP | 8.0M | $119.6M | +6.3% | 9.182% | 2.44% |
| 3 | Bain Capital Life Sciences Investors, LLC | 7.5M | $111.4M | -12.2% | 8.556% | 10.05% |
| 4 | JANUS HENDERSON GROUP PLC | 7.1M | $106.0M | +5.9% | 8.138% | 0.05% |
| 5 | BlackRock, Inc. | 5.7M | $84.3M | +1.6% | 6.471% | 0.00% |
| 6 | BVF INC/IL | 5.3M | $79.0M | 0.0% | 6.063% | 2.52% |
| 7 | Siren, L.L.C. | 4.8M | $70.9M | +44.1% | 5.446% | 1.97% |
| 8 | Cormorant Asset Management, LP | 4.4M | $65.6M | +60.0% | 5.037% | 3.29% |
| 9 | STATE STREET CORP | 3.9M | $58.7M | +109.0% | 4.508% | 0.00% |
| 10 | Logos Global Management LP | 3.2M | $47.8M | 0.0% | 3.674% | 2.39% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | $46.0M | — | 3.530% | 0.00% |
| 12 | RA CAPITAL MANAGEMENT, L.P. | 2.6M | $38.8M | 0.0% | 2.977% | 0.41% |
| 13 | JENNISON ASSOCIATES LLC | 1.8M | $27.2M | +89.0% | 2.086% | 0.02% |
| 14 | Polar Capital Holdings Plc | 1.6M | $23.9M | +16.1% | 1.835% | 0.08% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 1.5M | $23.0M | +22.8% | 1.768% | 0.00% |
| 16 | Defilade Capital Management, L.P. | 1.5M | $22.4M | +21.9% | 1.723% | 3.15% |
| 17 | Woodline Partners LP | 1.5M | $22.1M | +0.0% | 1.697% | 0.08% |
| 18 | Lightspeed Management Company, L.L.C. | 1.4M | $20.2M | -29.8% | 1.552% | 2.05% |
| 19 | GOLDMAN SACHS GROUP INC | 1.3M | $18.7M | +53.2% | 1.434% | 0.00% |
| 20 | FRANKLIN RESOURCES INC | 1.2M | $18.2M | -50.8% | 1.395% | 0.00% |
| 21 | MORGAN STANLEY | 1.2M | $18.1M | +82.6% | 1.392% | 0.00% |
| 22 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.2M | $18.0M | +33.5% | 1.382% | 0.00% |
| 23 | TWO SIGMA INVESTMENTS, LP | 1.2M | $17.4M | +197.1% | 1.339% | 0.01% |
| 24 | Ikarian Capital, LLC | 1.1M | $17.1M | +19.8% | 1.314% | 1.82% |
| 25 | CITADEL ADVISORS LLC | 1.1M | $16.5M | -19.5% | 1.267% | 0.01% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in OLMA — a direct measure of their conviction.
Filings activity in OLMA during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 191 | 4.5% | 175.39% | 24.60 pp | $1.51B | 33% |
| Q4 2025 | 200 | +63% | 199.99% | +122.63 pp | $2.26B | +238% |
| Q3 2025 | 123 | +0.8% | 77.36% | +42.83 pp | $668M | +124% |
| Q2 2025 | 122 | 8.3% | 34.53% | +6.81 pp | $298M | +25% |
| Q1 2025 | 133 | 15% | 27.72% | 18.94 pp | $239M | 41% |
| Q4 2024 | 156 | +21% | 46.66% | 32.27 pp | $403M | 41% |
| Q3 2024 | 129 | +3.2% | 78.93% | +6.69 pp | $681M | +9.3% |
| Q2 2024 | 125 | — | 72.24% | — | $623M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying OLMA stock.
Based on Q1 2026 13F filings, institutional ownership of Olema Pharmaceuticals, Inc. stands at 175.4%, held across 191 reporting institutions.
FMR LLC is the largest reported institutional holder of OLMA, with approximately 10,386,845 shares worth $0.15B as of Q1 2026.
Yes — 3 widely-followed marquee investors appear among the top 25 institutional holders of OLMA, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, CITADEL ADVISORS LLC.
Our composite Smart Money Score for OLMA is 46 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
44 institutions opened new positions in OLMA during Q1 2026, while 53 fully exited. 30 added to existing positions and 114 trimmed.
OLMA institutional ownership fell by 24.60 percentage points quarter-over-quarter, with a net change of -9 holders.
The top 10 institutions account for 59.3% of all reported 13F value in OLMA, and the top 25 account for 82.3%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Olema Pharmaceuticals, Inc. (OLMA) Institutional Ownership